SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-17-029848
Filing Date
2017-05-26
Accepted
2017-05-26 16:06:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D v467755_sc13d.htm SC 13D 52029
2 EXHIBIT 7.01 v467755_ex7-01.htm EX-7.01 56277
  Complete submission text file 0001144204-17-029848.txt   109983
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filed by) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Subject) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
Type: SC 13D | Act: 34 | File No.: 005-89875 | Film No.: 17873972
SIC: 2834 Pharmaceutical Preparations